Compare BNTC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTC | SOPH |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.7M | 330.4M |
| IPO Year | N/A | 2021 |
| Metric | BNTC | SOPH |
|---|---|---|
| Price | $11.55 | $5.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $27.67 | $7.00 |
| AVG Volume (30 Days) | 171.7K | ★ 214.2K |
| Earning Date | 02-13-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.48 |
| Revenue Next Year | N/A | $15.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $9.70 | $2.58 |
| 52 Week High | $17.15 | $5.55 |
| Indicator | BNTC | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 40.27 | 57.61 |
| Support Level | $11.40 | $5.00 |
| Resistance Level | $12.55 | $5.55 |
| Average True Range (ATR) | 0.84 | 0.34 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 10.69 | 57.05 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.